HUMA
Humacyte Inc

7,569
Loading...
Loading...
News
all
press releases
Is It Worth Investing in Humacyte, Inc. (HUMA) Based on Wall Street's Bullish Views?
According to the average brokerage recommendation (ABR), one should invest in Humacyte, Inc. (HUMA). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Zacks·23d ago
News Placeholder
More News
News Placeholder
Humacyte, Inc. (HUMA) Reports Q2 Loss, Misses Revenue Estimates
Humacyte, Inc. (HUMA) delivered earnings and revenue surprises of -60.00% and -73.60%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
Humacyte, Inc. (HUMA) Stock Dips While Market Gains: Key Facts
Humacyte, Inc. (HUMA) concluded the recent trading session at $2.21, signifying a -4.33% move from its prior day's close.
Zacks·1mo ago
News Placeholder
Humacyte, Inc. (HUMA) Suffers a Larger Drop Than the General Market: Key Insights
Humacyte, Inc. (HUMA) closed at $2.4 in the latest trading session, marking a -1.23% move from the prior day.
Zacks·1mo ago
News Placeholder
Humacyte, Inc. (HUMA) Stock Dips While Market Gains: Key Facts
Humacyte, Inc. (HUMA) concluded the recent trading session at $2.53, signifying a -5.24% move from its prior day's close.
Zacks·2mo ago
News Placeholder
Humacyte, Inc. (HUMA) Stock Falls Amid Market Uptick: What Investors Need to Know
Humacyte, Inc. (HUMA) closed at $2.67 in the latest trading session, marking a -2.2% move from the prior day.
Zacks·2mo ago
News Placeholder
Humacyte, Inc. (HUMA) Dips More Than Broader Market: What You Should Know
Humacyte, Inc. (HUMA) concluded the recent trading session at $2.33, signifying a -3.72% move from its prior day's close.
Zacks·2mo ago
News Placeholder
Why Humacyte, Inc. (HUMA) Dipped More Than Broader Market Today
Humacyte, Inc. (HUMA) closed at $2.28 in the latest trading session, marking a -7.69% move from the prior day.
Zacks·2mo ago
News Placeholder
Humacyte, Inc. (HUMA) Stock Declines While Market Improves: Some Information for Investors
The latest trading day saw Humacyte, Inc. (HUMA) settling at $2.54, representing a -1.17% change from its previous close.
Zacks·2mo ago
News Placeholder
Beat the Market the Zacks Way: Humacyte, Starbucks, Oracle in Focus
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.
Zacks·2mo ago

Latest HUMA News

View

Advertisement. Remove ads.

Advertisement. Remove ads.